Ozempic Copycats Restricted: U.S. Judge Upholds FDA Ruling on Semaglutide Compounding
On April 24, 2025, a U.S. judge rejected a bid by compounding pharmacies to continue producing copies of Novo Nordisk’s…
On April 24, 2025, a U.S. judge rejected a bid by compounding pharmacies to continue producing copies of Novo Nordisk’s…
In 2025, weight loss drugs have taken center stage in global health discussions — and Orforglipron, a new oral GLP-1…
In a remarkable development within the field of obesity medicine, researchers are exploring less invasive alternatives to injectable weight-loss drugs,…
Retatrutide, an investigational drug developed by Eli Lilly, is making waves in the field of obesity treatment. Currently in clinical…
Obesity and type 2 diabetes are often called “twin epidemics” — and for good reason. These two conditions not only…
Orforglipron and tirzepatide, developed by Eli Lilly, are cutting-edge treatments for type 2 diabetes and obesity. While both aim to…
Weight-loss injections like Ozempic and Wegovy have taken the world by storm — helping millions shed pounds and improve their…